TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1099491

Group type: EXPERIMENTAL
Intervention: AN448 (active drug)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 21
Study: 30904834

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg at the end of the surgical procedure and at day +1, n=611)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Placebo (n=611)
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1222
Study: 29135938

Group type: EXPERIMENTAL
Intervention: Lutein and Zeaxanthin supplementation
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 25153411

Group type: EXPERIMENTAL
Intervention: Highest uNGAL tertile
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Highest urine NGAL-to-creatinine ratio (UNCR) tertile
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Highest urine NGAL-to-protein ratio (UNPR) tertile
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Highest UNPR tertile
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Highest UNCR tertile
Number of subjects: 473
Study: 23783252

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy (LADG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open distal gastrectomy (ODG)
Number of subjects: 40
Study: 21784442

Group type: EXPERIMENTAL
Intervention: Furosemide (1 mg/kg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 51
Study: 19591334

Group type: EXPERIMENTAL
Intervention: SnF2/SHMP dentifrice
Number of subjects: 29

Group type: COMPARATOR
Intervention: AlF3/Chx dentifrice
Number of subjects: 29
Study: 16937132

Group type: EXPERIMENTAL
Intervention: Sonic tooth brushing and oral hygiene instruction
Number of subjects: 23

Group type: COMPARATOR
Intervention: Manual toothbrush (control group)
Number of subjects: 23
Study: 12740960

Group type: EXPERIMENTAL
Intervention: Traditional lateral cephalometric analysis
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Fourier soft-tissue profile analysis
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Prediction model based on 121 subjects
Number of subjects: 121
Study: 10695908

Group type: EXPERIMENTAL
Intervention: Sevoflurane in oxygen:nitrous oxide
Number of subjects: 75

Group type: COMPARATOR
Intervention: Propofol/alfentanil
Number of subjects: 75

Group type: COMPARATOR
Intervention: Propofol/remifentanil
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sevoflurane/nitrous oxide
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 75
Study: 9330783

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate metered-dose inhaler (CFC-free) at 50 micrograms/actuation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate metered-dose inhaler (CFC-free) at 100 micrograms/actuation
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate metered-dose inhaler (CFC-free) at 200 micrograms/actuation
Number of subjects: 13
Study: 8222650

Group type: EXPERIMENTAL
Intervention: 20 mcg ethinyl-estradiol (MERCILON)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 30 mcg ethinyl-estradiol (MARVELON)
Number of subjects: 49
Study: 3512535

Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 54
Study: 30919948

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine TAP block
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intrathecal (IT) opioid administration with hydromorphone
Number of subjects: 200
Study: 28474741

Group type: EXPERIMENTAL
Intervention: Metformin + Daclatasvir
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 20
Study: 25159700

Group type: EXPERIMENTAL
Intervention: MoodCare (telephone-delivered cognitive behavioural therapy and risk-reduction programme)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 121
Study: 23076706

Group type: EXPERIMENTAL
Intervention: Counseling (three sessions per week, each lasting 60-90 min)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 100
Study: 22191012

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19427633

Group type: EXPERIMENTAL
Intervention: 20 mg citalopram
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 12
Study: 16492852

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) added to lidocaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lidocaine (Control group)
Number of subjects: 30
Study: 16422972

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11731727

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 18
Study: 9400091

Group type: EXPERIMENTAL
Intervention: Velten manipulation with mirror
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Music manipulation with mirror
Number of subjects: 231

Group type: COMPARATOR
Intervention: Velten manipulation without mirror
Number of subjects: 231

Group type: COMPARATOR
Intervention: Music manipulation without mirror
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 231
Study: 8434274

Group type: EXPERIMENTAL
Intervention: Social support and health education program during pregnancy (4-6 home visits by social workers)
Number of subjects: 2236

Group type: EXPERIMENTAL
Intervention: Home visits by social workers
Number of subjects: 2236
Study: 3297265

Group type: EXPERIMENTAL
Intervention: Propafenone (150 mg quid)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Propafenone or Disopyramide
Number of subjects: 16
Study: 31724253

Group type: EXPERIMENTAL
Intervention: MYL‐1501D
Number of subjects: 114

Group type: COMPARATOR
Intervention: US reference insulin glargine (US IG)
Number of subjects: 114

Group type: COMPARATOR
Intervention: European reference insulin glargine (EU IG)
Number of subjects: 114
Study: 30453494

Group type: EXPERIMENTAL
Intervention: Pistacia lentiscus (PL) supplement (2.8 g/day) for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pistacia lentiscus (PL) supplement
Number of subjects: 60
Study: 28306134

Group type: EXPERIMENTAL
Intervention: Mandibular extension using a spring device with partial masticatory movements
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control procedure using a tongue depressor between incisor teeth
Number of subjects: 25
Study: 26011955

Group type: EXPERIMENTAL
Intervention: Individualized psychological interventions including psychological support, relaxation training, and humanistic care based on conventional nursing care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional nursing
Number of subjects: 100
Study: 22157664

Group type: EXPERIMENTAL
Intervention: Articaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 0
Study: 20339911

Group type: EXPERIMENTAL
Intervention: Parental Friendship Coaching (PFC) intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 62
Study: 18539540

Group type: EXPERIMENTAL
Intervention: Roux limb 150 cm, biliary limb 50 cm (Group 1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Roux limb 250 cm, biliary limb 100 cm (Group 2)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 105
Study: 16182832

Group type: EXPERIMENTAL
Intervention: tacrolimus and MMF
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: cyclosporine microemulsion (CsA‐ME) and MMF
Number of subjects: 205

Group type: COMPARATOR
Intervention: corticosteroid therapy (control group)
Number of subjects: 205
Study: 11509496

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (20 g/day for 5 days followed by 5 g/day for 3-4 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (glucose polymers)
Number of subjects: 27
Study: 9506757

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (0.2 mg/kg)
Number of subjects: 12
Study: 7522315

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (0.1% fluorometholone for 6 months)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Plasmin inhibitors (aprotinin 40 IU/ml for 3 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Plasmin inhibitors (aprotinin)
Number of subjects: 86
Study: 3351000

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate 12.5 mg intramuscularly every 2 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate withdrawal
Number of subjects: 12
Study: 30256319

Group type: EXPERIMENTAL
Intervention: Spring-loaded injector (NIO)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Battery power drill (EZ-IO)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ease of use (spring-loaded injector)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ease of use (battery power drill)
Number of subjects: 64
Study: 31780096

Group type: EXPERIMENTAL
Intervention: Multiple respiratory viral infections (≥2 strains)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Single or nondetectable viral infection
Number of subjects: 270
Study: 29852208

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 28231596

Group type: EXPERIMENTAL
Intervention: Senso-Motoric Training (SMT) - 30 minutes per day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional Strength Training (KT) - 30 minutes per day
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Senso-Motoric Training (SMT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional Strength Training (KT)
Number of subjects: 43
Study: 23425550

Group type: EXPERIMENTAL
Intervention: Low-fluoride public water supply in intervention villages (A-D)
Number of subjects: 480
Study: 21839757

Group type: EXPERIMENTAL
Intervention: Theobromine (700 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Caffeine (120 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of caffeine and theobromine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19453998

Group type: EXPERIMENTAL
Intervention: rapamycin
Number of subjects: 46

Group type: COMPARATOR
Intervention: tacrolimus
Number of subjects: 46

Group type: COMPARATOR
Intervention: mycophenolate mofetil
Number of subjects: 46
Study: 16712638

Group type: EXPERIMENTAL
Intervention: Joint attention intervention
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Symbolic play intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study: 15577539

Group type: EXPERIMENTAL
Intervention: Emtricitabine 200 mg QD
Number of subjects: 440

Group type: COMPARATOR
Intervention: Lamivudine 150 mg BID
Number of subjects: 440
Study: 11354919

Group type: EXPERIMENTAL
Intervention: Topical penciclovir applied every 2 hours during waking hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical acyclovir applied every 2 hours during waking hours
Number of subjects: 40
Study: 9241092

Group type: EXPERIMENTAL
Intervention: Carbamazepine with Valproate (N=10)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Carbamazepine alone (N=17)
Number of subjects: 27
Study: 8173850

Group type: EXPERIMENTAL
Intervention: NSAID plus placebo TENS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: TENS plus placebo drug
Number of subjects: 36

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PIPER ratings
Number of subjects: 36
Study: 3135588

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin for 1 week
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin for 3 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: No systemic antibiotics
Number of subjects: 62
Study: 31565730

Group type: EXPERIMENTAL
Intervention: Standard treatment for fit patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Best supportive or palliative care for frail patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Composite endpoints incorporating geriatric assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational study
Number of subjects: 0
Study: 28332360

Group type: COMPARATOR
Intervention: Entecavir (ETV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT)
Number of subjects: 60
Study: 25451631

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel hemorrhoidectomy (HSH)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Stapler hemorrhoidopexy (SH)
Number of subjects: 99
Study: 24660605

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus Xuebijing (XBJ) injection
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 63
Study: 21224045

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 784

Group type: COMPARATOR
Intervention: High ERCC1 scores
Number of subjects: 784
Study: 18203764

Group type: EXPERIMENTAL
Intervention: Etanercept and Methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiographic progression categories (negative, zero, minor, greater progression)
Number of subjects: 0
Study: 22143683

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 50
Study: 15483085

Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily) + hCG
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily) without hCG (P only)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (GnRH agonists)
Number of subjects: 15
Study: 12860217

Group type: EXPERIMENTAL
Intervention: TEE guided strategy with short‐term anticoagulation
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Conventional strategy
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: TEE guided strategy
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1222
Study: 9794851

Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Adequately concealed random allocation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-randomly selected control groups
Number of subjects: 11

Group type: COMPARATOR
Intervention: Inadequately concealed random allocation
Number of subjects: 11
Study: 8530808

Group type: EXPERIMENTAL
Intervention: Enterococcus faecium (SF68)
Number of subjects: 40

Group type: COMPARATOR
Intervention: lactulose
Number of subjects: 40
Study: 1023952

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Lignocaine 0.5%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Lignocaine 1%
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Lignocaine 2%
Number of subjects: 31
Study: 30535537

Group type: EXPERIMENTAL
Intervention: Octreotide SC depot 10 mg q2w
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Octreotide SC depot 20 mg q4w
Number of subjects: 12

Group type: COMPARATOR
Intervention: Octreotide IM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Octreotide SC depot
Number of subjects: 12
Study: 28768835

Group type: EXPERIMENTAL
Intervention: Total dairy consumption (≥14 servings/week)
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Low-fat dairy consumption (≥14 servings/week)
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: High-fat dairy consumption (≥14 servings/week)
Number of subjects: 2809

Group type: EXPERIMENTAL
Intervention: Cheese consumption (≥4 servings/week)
Number of subjects: 2809
Study: 25137296

Group type: EXPERIMENTAL
Intervention: Orally ingested colloidal silver nanoproduct
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standardized probes for P450 enzyme classes)
Number of subjects: 0
Study: 23261122

Group type: EXPERIMENTAL
Intervention: Intensive treatment (scaling and root planing, extraction of hopeless teeth, local-delivery antibiotics)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (treatment after 6 months)
Number of subjects: 53
Study: 21163915

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 162

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 162
Study: 18082778

Group type: EXPERIMENTAL
Intervention: Intraosseous administration of morphine sulfate (5 mg bolus)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous administration of morphine sulfate (5 mg bolus)
Number of subjects: 0
Study: 16820611

Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 190

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 190
Study: 12635911

Group type: EXPERIMENTAL
Intervention: Distant future behavior predictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-situational consistency predictions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information seeking about global dispositions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Global causal attributions
Number of subjects: 0
Study: 10710863

Group type: EXPERIMENTAL
Intervention: 1.5 mu of streptokinase (SK) infused in half an hour
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1.5 mu of streptokinase (SK) infused in one hour
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (1.5 mu in half an hour and 1.5 mu in one hour)
Number of subjects: 40
Study: 8938608

Group type: EXPERIMENTAL
Intervention: Closed wound suction drain placed deep to the lumbodorsal fascia before routine closure
Number of subjects: 200

Group type: COMPARATOR
Intervention: No drain placed after the surgical procedure
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Closed wound suction drain
Number of subjects: 200

Group type: COMPARATOR
Intervention: No drain placed
Number of subjects: 200
Study: 1543417

Group type: EXPERIMENTAL
Intervention: Iontophoresis of lidocaine hydrochloride
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 2864484

Group type: EXPERIMENTAL
Intervention: Red blood cells (RBCs) from CMV seronegative donors (group A)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Red blood cells (RBCs) from random donors (group B)
Number of subjects: 151

Group type: COMPARATOR
Intervention: No RBCs (group C)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Increased IgG titres with CMV-specific IgM antibody
Number of subjects: 151
Study: 29543538

Group type: EXPERIMENTAL
Intervention: Saffron (30 ml per day for 8 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 28701674

Group type: EXPERIMENTAL
Intervention: Resveratrol 100mg daily for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26329806

Group type: EXPERIMENTAL
Intervention: Total annual costs per patient
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Inpatient healthcare use
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Outpatient healthcare use
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Parental productivity loss
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Comparison of total costs between IBS and FAP/FAPS
Number of subjects: 258
Study: 23149973

Group type: EXPERIMENTAL
Intervention: ACDF-plate group
Number of subjects: 52

Group type: COMPARATOR
Intervention: ACDF-cage group
Number of subjects: 52
Study: 21952996

Group type: EXPERIMENTAL
Intervention: Elastic knee sleeve
Number of subjects: 74
Study: 18475166

Group type: EXPERIMENTAL
Intervention: 1-4 mg doxazosin (doxazosin group)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Control group (no add-on medication)
Number of subjects: 611
Study: 16571152

Group type: EXPERIMENTAL
Intervention: cis‐9,trans‐11 (c9,t11) CLA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: trans‐10,cis‐12 (t10,c12) CLA
Number of subjects: 15

Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 15
Study: 14521253

Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg/kg i.v.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane (6%+50% N2O+50% O2) by inhalation
Number of subjects: 100
Study: 12353420

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor) intake for 1 year
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 10
Study: 9574791

Group type: EXPERIMENTAL
Intervention: Allopurinol plus quinine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 47
Study: 7930335

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment in a geriatric day hospital
Number of subjects: 468
Study: 3259441

Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (dDAVP)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 31868776

Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study: 29649503

Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: multifocal tDCS (mftDCS)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: random noise stimulation (tRNS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: multifocal alternating current stimulation at 40 Hz (mftACS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: no-contact control group
Number of subjects: 82